Nu Skin Enterprises (NYSE: NUS) reported Q2 EPS of $1.15, $0.11 better than the analyst estimate of $1.04. Revenue for the quarter came in at $704.1 million versus the consensus estimate of $702.43 million.

GUIDANCE:

Nu Skin Enterprises sees Q3 2021 EPS of $1.10-$1.20, versus the consensus of $1.11. Nu Skin Enterprises sees Q3 2021 revenue of $700-730 million, versus the consensus of $730.56 million.

Nu Skin Enterprises sees FY2021 EPS of $4.30-$4.50, versus the consensus of $4.26. Nu Skin Enterprises sees FY2021 revenue of $2.81-2.87 billion, versus the consensus of $2.86 billion.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.